|
1
|
Sawyers C: Targeted cancer therapy.
Nature. 432:294–297. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou L, Xu N, Sun Y and Liu XM: Targeted
biopharmaceuticals for cancer treatment. Cancer Lett. 352:145–151.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Savage DG and Antman KH: Imatinib
mesylate--a new oral targeted therapy. N Engl J Med. 346:683–693.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bissell MJ, Weaver VM, Lelièvre SA, Wang
F, Petersen OW and Schmeichel KL: Tissue structure, nuclear
organization, and gene expression in normal and malignant breast.
Cancer Res. 59:1757–1763s; discussion 1763s–1764s. 1999.PubMed/NCBI
|
|
5
|
Weaver VM, Fischer AH, Peterson OW and
Bissell MJ: The importance of the microenvironment in breast cancer
progression: Recapitulation of mammary tumorigenesis using a unique
human mammary epithelial cell model and a three-dimensional culture
assay. Biochem Cell Biol. 74:833–851. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J, Richards J, Bowman P, Guzman R,
Enami J, McCormick K, Hamamoto S, Pitelka D and Nandi S: Sustained
growth and three-dimensional organization of primary mammary tumor
epithelial cells embedded in collagen gels. Proc Natl Acad Sci USA.
76:3401–3405. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lo AT, Mori H, Mott J and Bissell MJ:
Constructing three-dimensional models to study mammary gland
branching morphogenesis and functional differentiation. J Mammary
Gland Biol Neoplasia. 17:103–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cichon MA, Gainullin VG, Zhang Y and
Radisky DC: Growth of lung cancer cells in three-dimensional
microenvironments reveals key features of tumor malignancy. Integr
Biol Camb. 4:440–448. 2012. View Article : Google Scholar
|
|
9
|
Eke I, Schneider L, Förster C, Zips D,
Kunz-Schughart LA and Cordes N: EGFR/JIP-4/JNK2 signaling
attenuates cetuximab-mediated radiosensitization of squamous cell
carcinoma cells. Cancer Res. 73:297–306. 2013. View Article : Google Scholar
|
|
10
|
Eke I, Storch K, Krause M and Cordes N:
Cetuximab attenuates its cytotoxic and radiosensitizing potential
by inducing fibro-nectin biosynthesis. Cancer Res. 73:5869–5879.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Storch K, Eke I, Borgmann K, Krause M,
Richter C, Becker K, Schröck E and Cordes N: Three-dimensional cell
growth confers radioresistance by chromatin density modification.
Cancer Res. 70:3925–3934. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martin KJ, Patrick DR, Bissell MJ and
Fournier MV: Prognostic breast cancer signature identified from 3D
culture model accurately predicts clinical outcome across
independent datasets. PLoS One. 3:e29942008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamada KM and Cukierman E: Modeling tissue
morphogenesis and cancer in 3D. Cell. 130:601–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pampaloni F, Reynaud EG and Stelzer EHK:
The third dimension bridges the gap between cell culture and live
tissue. Nat Rev Mol Cell Biol. 8:839–845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fernandez-Fuente G, Mollinedo P, Grande L,
Vazquez-Barquero A and Fernandez-Luna JL: Culture dimensionality
influences the resistance of glioblastoma stem-like cells to
multi-kinase inhibitors. Mol Cancer Ther. 13:1664–1672. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marushima H, Shibata S, Asakura T,
Matsuura T, Maehashi H, Ishii Y, Eda H, Aoki K, Iida Y, Morikawa T,
et al: Three-dimensional culture promotes reconstitution of the
tumor-specific hypoxic microenvironment under TGFβ stimulation. Int
J Oncol. 39:1327–1336. 2011.PubMed/NCBI
|
|
17
|
Park CC, Zhang HJ, Yao ES, Park CJ and
Bissell MJ: Beta1 integrin inhibition dramatically enhances
radiotherapy efficacy in human breast cancer xenografts. Cancer
Res. 68:4398–4405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Damiano JS, Cress AE, Hazlehurst LA, Shtil
AA and Dalton WS: Cell adhesion mediated drug resistance (CAM-DR):
Role of integrins and resistance to apoptosis in human myeloma cell
lines. Blood. 93:1658–1667. 1999.PubMed/NCBI
|
|
19
|
Eke I, Deuse Y, Hehlgans S, Gurtner K,
Krause M, Baumann M, Shevchenko A, Sandfort V and Cordes N: β1
Integrin/FAK/cortactin signaling is essential for human head and
neck cancer resistance to radiotherapy. J Clin Invest.
122:1529–1540. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahmed KM, Zhang H and Park CC: NF-κB
regulates radioresistance mediated by β1-integrin in
three-dimensional culture of breast cancer cells. Cancer Res.
73:3737–3748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eke I, Zscheppang K, Dickreuter E,
Hickmann L, Mazzeo E, Unger K, Krause M and Cordes N: Simultaneous
β1 integrin-EGFR targeting and radiosensitization of human head and
neck cancer. J Natl Cancer Inst. 107:dju4192015. View Article : Google Scholar
|
|
22
|
Fournier MV and Martin KJ: Transcriptome
profiling in clinical breast cancer: From 3D culture models to
prognostic signatures. J Cell Physiol. 209:625–630. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee GY, Kenny PA, Lee EH and Bissell MJ:
Three-dimensional culture models of normal and malignant breast
epithelial cells. Nat Methods. 4:359–365. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eke I, Storch K, Kästner I, Vehlow A,
Faethe C, Mueller-Klieser W, Taucher-Scholz G, Temme A, Schackert G
and Cordes N: Three-dimensional invasion of human glioblastoma
cells remains unchanged by X-ray and carbon ion irradiation in
vitro. Int J Radiat Oncol Biol Phys. 84:e515–e523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu TJ, LaFortune T, Honda T, Ohmori O,
Hatakeyama S, Meyer T, Jackson D, de Groot J and Yung WK:
Inhibition of both focal adhesion kinase and insulin-like growth
factor-I receptor kinase suppresses glioma proliferation in vitro
and in vivo. Mol Cancer Ther. 6:1357–1367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tancioni I, Uryu S, Sulzmaier FJ, Shah NR,
Lawson C, Miller NL, Jean C, Chen XL, Ward KK and Schlaepfer DD:
FAK inhibition disrupts a β5 integrin signaling axis controlling
anchorage-independent ovarian carcinoma growth. Mol Cancer Ther.
13:2050–2061. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawakami K, Fujita Y, Kato T, Mizutani K,
Kameyama K, Tsumoto H, Miura Y, Deguchi T and Ito M: Integrin β4
and vinculin contained in exosomes are potential markers for
progression of prostate cancer associated with taxane-resistance.
Int J Oncol. 47:384–390. 2015.PubMed/NCBI
|
|
28
|
Matsuda Y, Kawamoto Y, Teduka K, Peng WX,
Yamamoto T, Ishiwata T and Naito Z: Morphological and cytoskeletal
alterations of nervous system tumor cells with different culturing
methods. Int J Oncol. 38:1253–1258. 2011.PubMed/NCBI
|
|
29
|
Nelson CM, Inman JL and Bissell MJ:
Three-dimensional lithographically defined organotypic tissue
arrays for quantitative analysis of morphogenesis and neoplastic
progression. Nat Protoc. 3:674–678. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roper PR and Drewinko B: Comparison of in
vitro methods to determine drug-induced cell lethality. Cancer Res.
36:2182–2188. 1976.PubMed/NCBI
|
|
31
|
Salmon SE, Hamburger AW, Soehnlen B, Durie
BG, Alberts DS and Moon TE: Quantitation of differential
sensitivity of human-tumor stem cells to anticancer drugs. N Engl J
Med. 298:1321–1327. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Puck TT, Morkovin D, Marcus PI and
Cieciura SJ: Action of x-rays on mammalian cells. II. Survival
curves of cells from normal human tissues. J Exp Med. 106:485–500.
1957. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schindelin J, Arganda-Carreras I, Frise E,
Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S,
Schmid B, et al: Fiji: An open-source platform for biological-image
analysis. Nat Methods. 9:676–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Team RC: R: a language and environment for
statistical computing. R Foundation for Statistical Computing;
Vienna, Austria: 2012, Open access available http://cran.r-project.org,
2014.
|
|
35
|
Eke I, Leonhardt F, Storch K, Hehlgans S
and Cordes N: The small molecule inhibitor QLT0267 Radiosensitizes
squamous cell carcinoma cells of the head and neck. PLoS One.
4:e64342009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luca AC, Mersch S, Deenen R, Schmidt S,
Messner I, Schäfer KL, Baldus SE, Huckenbeck W, Piekorz RP, Knoefel
WT, et al: Impact of the 3D microenvironment on phenotype, gene
expression, and EGFR inhibition of colorectal cancer cell lines.
PLoS One. 8:e596892013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Smyth T, Paraiso KHT, Hearn K,
Rodriguez-Lopez AM, Munck JM, Haarberg HE, Sondak VK, Thompson NT,
Azab M, Lyons JF, et al: Inhibition of HSP90 by AT13387 delays the
emergence of resistance to BRAF inhibitors and overcomes resistance
to dual BRAF and MEK inhibition in melanoma models. Mol Cancer
Ther. 13:2793–2804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Roobol A, Carden MJ, Newsam RJ and Smales
CM: Biochemical insights into the mechanisms central to the
response of mammalian cells to cold stress and subsequent
rewarming. FEBS J. 276:286–302. 2009. View Article : Google Scholar
|
|
39
|
Pattabiraman DR and Weinberg RA: Tackling
the cancer stem cells - what challenges do they pose? Nat Rev Drug
Discov. 13:497–512. 2014. View
Article : Google Scholar : PubMed/NCBI
|
